"10.1371_journal.pone.0128109","plos one","2015-05-26T00:00:00Z","Rachel F Tyndale; Andy Z X Zhu; Tony P George; Paul Cinciripini; Larry W Hawk; Robert A Schnoll; Gary E Swan; Neal L Benowitz; Daniel F Heitjan; Caryn Lerman; PGRN-PNAT Research Group","Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Division of Brain & Therapeutics, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Behavioral Science, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America; Department of Psychology, University at Buffalo, State University of New York (SUNY), Buffalo, New York, United States of America; Center for Children and Families, University at Buffalo, State University of New York (SUNY), Buffalo, New York, United States of America; Center for Interdisciplinary Research on Nicotine Addiction, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America; Department of Medicine, Stanford University, Palo Alto, California, United States of America; Department of Medicine, University of California San Francisco, San Francisco, California, United States of America; Department of Bioengineering & Therapeutic Sciences, University of California San Francisco, San Francisco, California, United States of America; Department of Biostatistics & Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America","Conceived and designed the experiments: RFT AZZ TPG PC LWH RAS GES NLB DJH CL. Performed the experiments: RFT AZZ. Analyzed the data: AZZ DFH. Wrote the paper: RFT AZZ TPG PC LWH RAS GES NLB DJH CL.","Lerman received study medication and placebo, as well as support for medication packaging, from Pfizer. She has also consulted to Gilead, and has been a paid expert witness in litigation against tobacco companies. Cinciripini served on the scientific advisory board of Pfizer Pharmaceuticals, conducted educational talks sponsored by Pfizer on smoking cessation from 2006-2008, and has received grant support from Pfizer. Schnoll received medication and placebo free of charge from Pfizer for a different project, and has consulted to Pfizer and GlaxoSmithKline. George has had both investigator-initiated and industry-sponsored grants from Pfizer in the past 12 months, and serves on a Data Monitoring Committee for Novartis. Benowitz has served as a consultant to several pharmaceutical companies that market smoking cessation medications and has been a paid expert witness in litigation against tobacco companies. Tyndale has acted as a consultant to pharmaceutical companies, primarily on smoking cessation. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The remaining authors report no conflicts of interest.","2015","05","Rachel F Tyndale","RFT",11,TRUE,10,2,2,10,TRUE,FALSE,TRUE,1,"11",TRUE
